Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, S… Read more
Market Cap & Net Worth: Sanofi India Limited (SANOFI)
Sanofi India Limited (NSE:SANOFI) has a market capitalization of $956.02 Million (₹82.80 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #11709 globally and #502 in its home market, demonstrating a -6.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sanofi India Limited's stock price ₹3595.00 by its total outstanding shares 23030622 (23.03 Million).
Sanofi India Limited Market Cap History: 2015 to 2026
Sanofi India Limited's market capitalization history from 2015 to 2026. Data shows growth from $896.34 Million to $956.02 Million (1.68% CAGR).
Index Memberships
Sanofi India Limited is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$1.33 Trillion | 0.03% | #396 of 500 |
|
NIFTY DIVIDEND OPPORTUNITIES 50
NIFTYDVOP
|
$350.06 Billion | 0.11% | #44 of 49 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.62 Billion | 0.07% | #288 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.03% | #426 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.43 Billion | 0.20% | #178 of 250 |
Weight: Sanofi India Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sanofi India Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sanofi India Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Sanofi India Limited's market cap is 0.06 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.33x
Sanofi India Limited's market cap is 0.33 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $888.91 Million | $23.67 Billion | $3.04 Billion | 0.04x | 0.29x |
| 2017 | $995.24 Million | $24.64 Billion | $3.26 Billion | 0.04x | 0.31x |
| 2018 | $1.36 Billion | $27.71 Billion | $3.81 Billion | 0.05x | 0.36x |
| 2019 | $1.51 Billion | $30.71 Billion | $4.14 Billion | 0.05x | 0.36x |
| 2020 | $1.87 Billion | $29.02 Billion | $4.78 Billion | 0.06x | 0.39x |
| 2021 | $1.83 Billion | $29.57 Billion | $9.44 Billion | 0.06x | 0.19x |
| 2022 | $1.43 Billion | $27.70 Billion | $6.21 Billion | 0.05x | 0.23x |
| 2023 | $2.10 Billion | $19.96 Billion | $6.03 Billion | 0.11x | 0.35x |
| 2024 | $1.63 Billion | $20.13 Billion | $4.13 Billion | 0.08x | 0.39x |
| 2025 | $1.09 Billion | $18.37 Billion | $3.27 Billion | 0.06x | 0.33x |
Competitor Companies of SANOFI by Market Capitalization
Companies near Sanofi India Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Sanofi India Limited by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Sanofi India Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Sanofi India Limited's market cap moved from $896.34 Million to $ 956.02 Million, with a yearly change of 1.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹956.02 Million | -12.04% |
| 2025 | ₹1.09 Billion | -33.24% |
| 2024 | ₹1.63 Billion | -22.62% |
| 2023 | ₹2.10 Billion | +46.97% |
| 2022 | ₹1.43 Billion | -21.76% |
| 2021 | ₹1.83 Billion | -2.37% |
| 2020 | ₹1.87 Billion | +24.20% |
| 2019 | ₹1.51 Billion | +11.27% |
| 2018 | ₹1.36 Billion | +36.25% |
| 2017 | ₹995.24 Million | +11.96% |
| 2016 | ₹888.91 Million | -0.83% |
| 2015 | ₹896.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Sanofi India Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $956.02 Million USD |
| MoneyControl | $956.02 Million USD |
| MarketWatch | $956.02 Million USD |
| marketcap.company | $956.02 Million USD |
| Reuters | $956.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.